Journal: Case Reports in Gastroenterology
Submission Deadline: December 31, 2025
Case Reports in Gastroenterology is calling for submissions of case reports or case series highlighting the use of immunotherapy in the treatment gastrointestinal (GI) cancers. As the development of immunotherapeutic strategies continues to reshape the oncology landscape, we seek detailed clinical narratives that highlight their application, efficacy, and challenges in GI malignancies.
We welcome submissions that explore:
- Responses to checkpoint inhibitors in colorectal, gastric, esophageal, pancreatic, and hepatobiliary cancers.
- Management of immune-related adverse events (irAEs) in GI settings.
- Novel insights into immunotherapy resistance or combination strategies.
- Rare or unexpected outcomes that can inform clinical practice.
Each case report should emphasize diagnostic reasoning, therapeutic decision-making, and clinical outcomes.
Please select the option “Call for Papers: The Use of Immunotherapy for Gastrointestinal Cancer” when submitting your manuscript and mention this Call for Papers in your cover letter.
Article publication is subject to rigorous peer review in line with the journal's editorial policies. Please refer to our author guidelines for further details about the publication conditions.
Karger has established agreements with consortia and institutions that include full or partial coverage of Article Processing Charges (APC). Corresponding authors can publish Open Access articles at no or reduced cost if they are associated with or employed by one of these universities/institutions.